entacapone protective_against cannabis dependence
Evidence from:
primary |
all sources
Evidence (2 sources)
Entacapone both short-term and long-term significantly decreased craving for cannabis in 52.7% of the patients
confidence: 0.90
small open-label clinical trials suggest that the COMT inhibitor entacapone ... may warrant further study.
confidence: 0.70